Providing Oral PrEP

Video Series: Lessons from the Field

Oral PrEP will reach women who need it if PrEP programs are well-supported and prepared. A collaboration between LVCT Health in Kenya and AVAC, through the USAID-funded OPTIONS Consortium, this video series shows how LVCT Health made changes at the site level and helped women interested in oral PrEP overcome recurring barriers to uptake and adherence.

Each film in the series highlights a different theme or challenge that emerged as PrEP rolled out, and tells the story of how the project responded–and has an accompanying commentary as well. This series is intended to foster innovation and problem-solving among key PrEP stakeholders, including program implementers, policy makers, civil society, advocates and people considering PrEP.

Click here for a one-page summary of lessons learned. And we'd love to hear your thoughts on this series! If you're an implementer, fill out a survey here. Everyone else, please click here.

If you're having trouble watching the videos below, you may also download them.

Getting Women in the Door

Issue: Women find it difficult to come to a clinic for oral PrEP services because of stigma. Additionally, taking medicine for prevention is not a common practice.
Key Findings: Testing in the community, reaching women where they access family planning or other services, and peer to peer encouragement increased the number of women accessing oral PrEP.

Click for an accompanying blog and additional resources.

Stigma and Pill Taking

Issue: Stigma, travel and work make daily pill taking complicated for many women.
Key Findings: LVCT Health helped women develop pill taking strategies that worked for individuals’ unique situations.

Click for an accompanying blog and additional resources.

Making Oral PrEP Services Work for Women

Issue: Women are more likely to start and continue oral PrEP if clinics offer an accommodating and welcoming experience.
Key Findings: Integrated services, sensitized staff, adjusted clinic hours, support groups and hotline numbers encouraged women to take up and stay on oral PrEP.

Click for an accompanying blog and additional resources.

Messages and Myths

Issue: Myths and confusing messaging surround oral PrEP.
Key Findings: Delivering accurate messages consistently will be necessary for women to accept oral PrEP.

Click for an accompanying blog and additional resources.

Month One

Issue: Women who begin oral PrEP often do not continue after the first month due to side effects, stigma, and the burden of a daily pill.
Key Findings: Programs can minimize drop off during month one with continuous communication, easy access to staff and support groups.

Click for an accompanying blog and additional resources.


Issue: Men often have the power to decide if a woman uses oral PrEP.
Key Findings: Programs trying to reach women need to actively engage men who act as “gatekeepers” for women considering starting oral PrEP.

Click for an accompanying blog and additional resources.

News Spotlight

  • FDA Approves Truvada as PrEP for Adolescents at Risk for HIV

    May 15, 2018

    The US Food and Drug Administration has expanded the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV to include adolescents. Truvada was approved as an HIV prevention method in 2012 but only for individuals age 18 and older. The new approval expands this indication to include adults and adolescents at risk for HIV.

    Read more

  • Early PrEP Uptake in Africa Study Gives Support for Possibility of Wider Acceptance

    May 9, 2018

    New findings show that nearly a fifth of adults whose risk for HIV infection made them eligible for free PrEP started taking the drug within 30 days — according to a study examining the impacts of health interventions across communities in two East African countries. The study’s authors conclude that this provides further evidence that widespread roll out of PrEP to individuals at high risks for infection across resource-limited communities is feasible.

    Read more